Form 8-K - Current report:
SEC Accession No. 0000950170-25-004612
Filing Date
2025-01-13
Accepted
2025-01-13 09:09:12
Documents
59
Period of Report
2025-01-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dsgn-20250113.htm   iXBRL 8-K 45928
2 EX-99.1 dsgn-ex99_1.htm EX-99.1 47487
3 GRAPHIC img267412975_0.jpg GRAPHIC 63947
4 GRAPHIC img267412975_1.jpg GRAPHIC 324528
5 GRAPHIC img267412975_2.jpg GRAPHIC 84504
6 GRAPHIC img267412975_3.jpg GRAPHIC 145073
7 GRAPHIC img267412975_4.jpg GRAPHIC 110640
8 GRAPHIC img267412975_5.jpg GRAPHIC 131945
9 GRAPHIC img267412975_6.jpg GRAPHIC 112524
10 GRAPHIC img267412975_7.jpg GRAPHIC 50815
11 GRAPHIC img267412975_8.jpg GRAPHIC 118081
12 GRAPHIC img267412975_9.jpg GRAPHIC 93300
13 GRAPHIC img267412975_10.jpg GRAPHIC 110159
14 GRAPHIC img267412975_11.jpg GRAPHIC 92705
15 GRAPHIC img267412975_12.jpg GRAPHIC 135512
16 GRAPHIC img267412975_13.jpg GRAPHIC 123986
17 GRAPHIC img267412975_14.jpg GRAPHIC 141816
18 GRAPHIC img267412975_15.jpg GRAPHIC 137793
19 GRAPHIC img267412975_16.jpg GRAPHIC 117348
20 GRAPHIC img267412975_17.jpg GRAPHIC 86760
21 GRAPHIC img267412975_18.jpg GRAPHIC 119484
22 GRAPHIC img267412975_19.jpg GRAPHIC 78310
23 GRAPHIC img267412975_20.jpg GRAPHIC 121599
24 GRAPHIC img267412975_21.jpg GRAPHIC 101693
25 GRAPHIC img267412975_22.jpg GRAPHIC 114708
26 GRAPHIC img267412975_23.jpg GRAPHIC 56589
27 GRAPHIC img267412975_24.jpg GRAPHIC 150374
28 GRAPHIC img267412975_25.jpg GRAPHIC 138627
29 GRAPHIC img267412975_26.jpg GRAPHIC 115292
30 GRAPHIC img267412975_27.jpg GRAPHIC 106255
31 GRAPHIC img267412975_28.jpg GRAPHIC 106588
32 GRAPHIC img267412975_29.jpg GRAPHIC 101082
33 GRAPHIC img267412975_30.jpg GRAPHIC 119473
34 GRAPHIC img267412975_31.jpg GRAPHIC 132324
35 GRAPHIC img267412975_32.jpg GRAPHIC 51889
36 GRAPHIC img267412975_33.jpg GRAPHIC 128827
37 GRAPHIC img267412975_34.jpg GRAPHIC 101858
38 GRAPHIC img267412975_35.jpg GRAPHIC 93022
39 GRAPHIC img267412975_36.jpg GRAPHIC 79792
40 GRAPHIC img267412975_37.jpg GRAPHIC 49550
41 GRAPHIC img267412975_38.jpg GRAPHIC 122283
42 GRAPHIC img267412975_39.jpg GRAPHIC 111864
43 GRAPHIC img267412975_40.jpg GRAPHIC 106517
44 GRAPHIC img267412975_41.jpg GRAPHIC 111185
45 GRAPHIC img267412975_42.jpg GRAPHIC 108708
46 GRAPHIC img267412975_43.jpg GRAPHIC 92039
47 GRAPHIC img267412975_44.jpg GRAPHIC 113040
48 GRAPHIC img267412975_45.jpg GRAPHIC 136856
49 GRAPHIC img267412975_46.jpg GRAPHIC 107351
  Complete submission text file 0000950170-25-004612.txt   7463762

Data Files

Seq Description Document Type Size
50 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT dsgn-20250113.xsd EX-101.SCH 26968
61 EXTRACTED XBRL INSTANCE DOCUMENT dsgn-20250113_htm.xml XML 5111
Mailing Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011
Business Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011 858-293-4900
Design Therapeutics, Inc. (Filer) CIK: 0001807120 (see all company filings)

EIN.: 823929248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40288 | Film No.: 25525067
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)